Orchard Hill Reports a 10% Stake in Supernus Pharmaceuticals

Orchard Hill, Supernus Pharmaceuticals: Earlier this year, Orchard Hill Capital Management purchased a position in Supernus Pharmaceuticals Inc (NASDAQ:SUPN) which contained 3.5 million shares, a new filing with the SEC stated. Orchard Hill holds 10.2% of the company.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

Disclosure: none

Sign Up

Get the InvestingChannel
Free e-Letter Today

Learn More

Independent market opinion, analysis and ideas - delivered every business day

Premium market opinions, analysis, and ideas - delivered every business day

Editor's Picks